Exercise News and Research

Latest Exercise News and Research

Top weight-loss behaviors

Losing weight and saving money are the top New Year's resolutions expected to vex Americans this year, experts say.

29 Dec 2010

Santarus, Pharming submit RHUCIN BLA to FDA for treatment of HAE attacks

Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).

29 Dec 2010

Majority of Americans hopeful for renewed commitment to fitness in 2011

Buoyed by the chance for a fresh start in the New Year, an overwhelming majority of Americans are hopeful for a renewed commitment to fitness in 2011, according to a national omnibus survey conducted by 24 Hour Fitness. 24 Hour Fitness, the largest privately-owned U.S. fitness club chain and a leading health club industry pioneer, recently commissioned the study to measure consumer attitudes about exercise and the obstacles that most often prevent people from pursuing a fit lifestyle.

28 Dec 2010

Pros and cons of apps for common New Year's resolutions

With about 400,000 apps available for Smartphones and news ones added daily, there is an app for almost everything, from losing weight to finding a job.

24 Dec 2010

AMPK activates autophagy by activating ATG1 enzyme

Researchers at the Salk Institute for Biological Studies have discovered how AMPK, a metabolic master switch that springs into gear when cells run low on energy, revs up a cellular recycling program to free up essential molecular building blocks in times of need.

24 Dec 2010

Molecular-level insights into how physical activity influences the heart

Everyone knows that exercise comes with metabolic and cardiovascular benefits, but scientists understand surprisingly little about how physical activity influences the heart itself. Now, a new study in the December 23rd issue of Cell, a Cell Press publication, offers some of the first molecular-level insights.

24 Dec 2010

Scientists tweak gene to mimick heart-strengthening effects of endurance training in sedentary mice

By tweaking a single gene, scientists have mimicked in sedentary mice the heart-strengthening effects of two weeks of endurance training, according to a report from Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center (BIDMC).

24 Dec 2010

YM Biosciences underwriters exercise Over-Allotment Option in full

YM BioSciences Inc. announced today that, in connection with its previously announced public offering for total net proceeds before expenses of US $37,650,000, the underwriters have exercised in full their Over-Allotment Option to purchase an additional 3,750,000 common shares of YM at US $1.60 per share for additional net proceeds of US $5,665,000.

24 Dec 2010

Alimera receives FDA CRL for ILUVIEN NDA

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN® for the treatment of Diabetic Macular Edema (DME), today announced that Alimera Sciences, Inc, pSivida's collaborative partner, received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ILUVIEN. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.

24 Dec 2010

Great River Foundation awarded 2-year Wellmark Foundation grant to fight childhood obesity

The Great River Foundation, which is affiliated with Great River Health Systems, has been awarded a two-year grant from the Wellmark Foundation to help fight childhood obesity. The funding will be used to begin a new school-based exercise program at two Burlington elementary schools.

23 Dec 2010

Zogenix announces underwriters partial exercise of over-allotment option in initial public offering

Zogenix, Inc. announced today that the underwriters of its recently completed initial public offering of common stock have partially exercised their option to purchase shares of common stock from Zogenix to cover over-allotments. The sale of additional shares is expected to close on December 27, 2010.

23 Dec 2010

Mobile trends, FDA regulations to be explored at Digital Health Summit 2011

Mobile technology has changed the way we live our lives. Going beyond business productivity, mobile devices have become the preferred way for consumers to manage everything from their finances to personal health, with the latter being the fastest growing corner of the category.

23 Dec 2010

Values-based approach for making more effective New Year's Resolutions

Dr. Richard Blonna, author, life coach, and stress management expert, offers a simple, values-based approach for making more effective New Year's Resolutions.

23 Dec 2010

Dieting trends in 2011

As the hectic holiday season comes to a close and a new year approaches, many consumers are once again vowing to adopt weight loss goals to shed those unwanted pounds. But with obesity increasing at alarming levels across the globe, a number of health experts are urging a new approach to help fight the nation's burgeoning weight problem.

23 Dec 2010

Obese people more likely to report exercise as a trigger for asthma

Obese people are more likely to report exercise as a trigger for asthma. Of 673 people evaluated in a new study whose results are published in the journal The Physician and Sportsmedicine, 71 percent of participants reported exercise-induced asthma (ETA).

23 Dec 2010

GE Healthcare announces completion of tender offer for Clarient

GE Healthcare, a unit of General Electric Company announced today that it has completed the tender offer by GE's wholly owned subsidiary, Crane Merger Sub, Inc., for all outstanding shares of common and preferred stock of Clarient Inc., a leading player in the fast-growing molecular diagnostics sector. Clarient provides pathologists and oncologists with access to key diagnostic tests that shed light on the complex nature of various cancers.

23 Dec 2010

Amylin, Lilly submit BYETTA sNDA for type 2 diabetes

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that a supplemental New Drug Application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for the expanded use of BYETTA® (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with type 2 diabetes who are not achieving adequate glycemic control.

23 Dec 2010

Takeda completes settlements in patent litigation over generic ACTOS, ACTOplus met, and duetact ANDAs

Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc. ("TPNA"), have completed settlements with all defendants in patent litigation brought against the companies in response to their Abbreviated New Drug Applications ("ANDAs") for generic ACTOS® (pioglitazone HCl), ACTOplus met® (pioglitazone HCl and metformin HCl), and duetact® (pioglitazone HCl and glimepiride).

22 Dec 2010

Exercise and Vitamin D supplementation most effective in reducing fall among seniors

A systematic review of over 50 clinical trials finds that exercise and Vitamin D supplements are the best ways to reduce the risk of falling in people aged 65 and over. The review is published in the December 21 issue of Annals of Internal Medicine and was commissioned by the US Preventive Services Task Force.

22 Dec 2010

Gym injury prevention advice for the New Year

The American Orthopaedic Foot & Ankle Society (AOFAS) has a message for previously sedentary Americans who will head to the gym this New Year: take it slow. Stress fractures are the most common overuse injuries of the foot and ankle. They occur with a rapid increase in physical activity (too much too quickly). Stress fractures result from a series of loading and unloading cycles that cause damage to the bone. If these forces continue and the bone is not able to repair itself fast enough, a fracture may occur.

21 Dec 2010